Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model
- 583 Downloads
Older people are often prescribed multiple medicines and have a high prevalence of polypharmacy. Polypharmacy is associated with an increased risk of inappropriate use of medicines and drug-related problems. As experts in pharmacotherapy, pharmacists are well placed to review complex medication regimens and identify causes of drug-related problems and recommend solutions to prevent or resolve them. Involvement in medication review services represents a major philosophical shift and paradigm change in the way pharmacists practice, in that the focus is shifted away from the dispensing of prescription medicines to the provision of a professional service for a patient, in collaboration with their general practitioner (GP). In Australia, there are two established medication review programs: Home Medicines Review (HMR) and Residential Medication Management Review (RMMR). The objectives of this article were to describe the process of government-funded medication review services in Australia and to evaluate the contribution of pharmacists to HMR and RMMR, using evidence-based measures, such as the Drug Burden Index (DBI) and the Medication Appropriateness Index (MAI). This review found that there is good evidence to support the role of pharmacists in delivering medication review services across different settings. Although the positive impact of such services has been demonstrated using a variety of validated measures (DBI, MAI), there remains a need to also evaluate actual clinical outcomes and/or patient-reported outcomes.
KeywordsMedication Review Aged Care Facility Home Medicine Review Drug Burden Index Medication Appropriateness Index
The European Society of Clinical Pharmacy is greatly acknowledged for organizing and holding their 42nd conference, at which the content of this manuscript was presented.
Compliance with Ethical Standards
No funding was received for the writing of this manuscript.
Conflicts of interest
The author has no conflicts of interest relating to the content of this manuscript.
- 1.World Health Organization. Ageing and life course: interesting facts about ageing. Geneva: WHO; 2012. Online at http://www.who.int/ageing/about/facts/en/index.html#. Accessed 19 Jan 2016.
- 2.Australian Government: The Treasury. Intergenerational report 2010. Australia to 2050: future challenges. Barton: Treasurury of the Commonwealth of Australia; 2010. Online at http://archive.treasury.gov.au/igr/igr2010/report/html/00_Preliminaries.asp. Accessed 19 Jan 2016.
- 3.Pillans P. Elderly patients and polypharmacy. NPS News. 2000;13Google Scholar
- 5.Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Br J Clin Pharmacol. 2012;65:989–95.Google Scholar
- 11.Australian Institute of Health and Welfare. Australia’s health 2014. Australia’s health series, no. 14. Volume Cat. no. AUS 178. Canberra: AIHW; 2014.Google Scholar
- 12.Australian Government Department of Health. National Medicines Policy. Online at http://www.health.gov.au/nationalmedicinespolicy. Accessed 19 Jan 2016.
- 13.Australian Government Department of Health. The National Medicines Policy document. Online at http://www.health.gov.au/internet/main/publishing.nsf/content/National+Medicines+Policy-2. Accessed 19 Jan 2016.
- 14.Australian Government Department of Health. Medication management reviews. Online at https://www.health.gov.au/internet/main/publishing.nsf/Content/medication_management_reviews.htm. Accessed 19 Jan 2016.
- 16.Chen TF, Crampton M, Krass I, Benrimoj SI. Collaboration between community pharmacists and GPs: impact on interprofessional communication. J Soc Adm Pharm. 2001;18(3):83–90.Google Scholar
- 31.Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47(8):891–6.CrossRefPubMedGoogle Scholar